Cargando…
Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment
BACKGROUND: In order to define adequate radiation portals in nodal positive prostate cancer a detailed knowledge of the anatomic lymph-node distribution is mandatory. We therefore systematically analyzed the localization of Choline PET/CT positive lymph nodes and compared it to the RTOG recommendati...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788881/ https://www.ncbi.nlm.nih.gov/pubmed/26968955 http://dx.doi.org/10.1186/s13014-016-0615-9 |
_version_ | 1782420783207809024 |
---|---|
author | Hegemann, Nina-Sophie Wenter, Vera Spath, Sonja Kusumo, Nadia Li, Minglun Bartenstein, Peter Fendler, Wolfgang P. Stief, Christian Belka, Claus Ganswindt, Ute |
author_facet | Hegemann, Nina-Sophie Wenter, Vera Spath, Sonja Kusumo, Nadia Li, Minglun Bartenstein, Peter Fendler, Wolfgang P. Stief, Christian Belka, Claus Ganswindt, Ute |
author_sort | Hegemann, Nina-Sophie |
collection | PubMed |
description | BACKGROUND: In order to define adequate radiation portals in nodal positive prostate cancer a detailed knowledge of the anatomic lymph-node distribution is mandatory. We therefore systematically analyzed the localization of Choline PET/CT positive lymph nodes and compared it to the RTOG recommendation of pelvic CTV, as well as to previous work, the SPECT sentinel lymph node atlas. METHODS: Thirty-two patients being mostly high risk patients with a PSA of 12.5 ng/ml (median) received PET/CT before any treatment. Eighty-seven patients received PET/CT for staging due to biochemical failure with a median PSA of 3.12 ng/ml. Each single PET-positive lymph node was manually contoured in a “virtual” patient dataset to achieve a 3-D visualization, resulting in an atlas of the cumulative PET positive lymph node distribution. Further the PET-positive lymph node location in each patient was assessed with regard to the existence of a potential geographic miss (i.e. PET-positive lymph nodes that would not have been treated adequately by the RTOG consensus on CTV definition of pelvic lymph nodes). RESULTS: Seventy-eight and 209 PET positive lymph nodes were detected in patients with no prior treatment and in postoperative patients, respectively. The most common sites of PET positive lymph nodes in patients with no prior treatment were external iliac (32.1 %), followed by common iliac (23.1 %) and para-aortic (19.2 %). In postoperative patients the most common sites of PET positive lymph nodes were common iliac (24.9 %), followed by external iliac (23.0 %) and para-aortic (20.1 %). In patients with no prior treatment there were 34 (43.6 %) and in postoperative patients there were 77 (36.8 %) of all detected lymph nodes that would not have been treated adequately using the RTOG CTV. We compared the distribution of lymph nodes gained by Choline PET/CT to the preexisting SPECT sentinel lymph node atlas and saw an overall good congruence. CONCLUSIONS: Choline PET/CT and SPECT sentinel lymph node atlas are comparable to each other. More than one-third of the PET positive lymph nodes in patients with no prior treatment and in postoperative patients would not have been treated adequately using the RTOG CTV. To reduce geographical miss, image based definition of an individual target volume is necessary. |
format | Online Article Text |
id | pubmed-4788881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47888812016-03-13 Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment Hegemann, Nina-Sophie Wenter, Vera Spath, Sonja Kusumo, Nadia Li, Minglun Bartenstein, Peter Fendler, Wolfgang P. Stief, Christian Belka, Claus Ganswindt, Ute Radiat Oncol Research BACKGROUND: In order to define adequate radiation portals in nodal positive prostate cancer a detailed knowledge of the anatomic lymph-node distribution is mandatory. We therefore systematically analyzed the localization of Choline PET/CT positive lymph nodes and compared it to the RTOG recommendation of pelvic CTV, as well as to previous work, the SPECT sentinel lymph node atlas. METHODS: Thirty-two patients being mostly high risk patients with a PSA of 12.5 ng/ml (median) received PET/CT before any treatment. Eighty-seven patients received PET/CT for staging due to biochemical failure with a median PSA of 3.12 ng/ml. Each single PET-positive lymph node was manually contoured in a “virtual” patient dataset to achieve a 3-D visualization, resulting in an atlas of the cumulative PET positive lymph node distribution. Further the PET-positive lymph node location in each patient was assessed with regard to the existence of a potential geographic miss (i.e. PET-positive lymph nodes that would not have been treated adequately by the RTOG consensus on CTV definition of pelvic lymph nodes). RESULTS: Seventy-eight and 209 PET positive lymph nodes were detected in patients with no prior treatment and in postoperative patients, respectively. The most common sites of PET positive lymph nodes in patients with no prior treatment were external iliac (32.1 %), followed by common iliac (23.1 %) and para-aortic (19.2 %). In postoperative patients the most common sites of PET positive lymph nodes were common iliac (24.9 %), followed by external iliac (23.0 %) and para-aortic (20.1 %). In patients with no prior treatment there were 34 (43.6 %) and in postoperative patients there were 77 (36.8 %) of all detected lymph nodes that would not have been treated adequately using the RTOG CTV. We compared the distribution of lymph nodes gained by Choline PET/CT to the preexisting SPECT sentinel lymph node atlas and saw an overall good congruence. CONCLUSIONS: Choline PET/CT and SPECT sentinel lymph node atlas are comparable to each other. More than one-third of the PET positive lymph nodes in patients with no prior treatment and in postoperative patients would not have been treated adequately using the RTOG CTV. To reduce geographical miss, image based definition of an individual target volume is necessary. BioMed Central 2016-03-11 /pmc/articles/PMC4788881/ /pubmed/26968955 http://dx.doi.org/10.1186/s13014-016-0615-9 Text en © Hegemann et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hegemann, Nina-Sophie Wenter, Vera Spath, Sonja Kusumo, Nadia Li, Minglun Bartenstein, Peter Fendler, Wolfgang P. Stief, Christian Belka, Claus Ganswindt, Ute Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment |
title | Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment |
title_full | Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment |
title_fullStr | Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment |
title_full_unstemmed | Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment |
title_short | Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment |
title_sort | distribution of prostate nodes: a pet/ct-derived anatomic atlas of prostate cancer patients before and after surgical treatment |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788881/ https://www.ncbi.nlm.nih.gov/pubmed/26968955 http://dx.doi.org/10.1186/s13014-016-0615-9 |
work_keys_str_mv | AT hegemannninasophie distributionofprostatenodesapetctderivedanatomicatlasofprostatecancerpatientsbeforeandaftersurgicaltreatment AT wentervera distributionofprostatenodesapetctderivedanatomicatlasofprostatecancerpatientsbeforeandaftersurgicaltreatment AT spathsonja distributionofprostatenodesapetctderivedanatomicatlasofprostatecancerpatientsbeforeandaftersurgicaltreatment AT kusumonadia distributionofprostatenodesapetctderivedanatomicatlasofprostatecancerpatientsbeforeandaftersurgicaltreatment AT liminglun distributionofprostatenodesapetctderivedanatomicatlasofprostatecancerpatientsbeforeandaftersurgicaltreatment AT bartensteinpeter distributionofprostatenodesapetctderivedanatomicatlasofprostatecancerpatientsbeforeandaftersurgicaltreatment AT fendlerwolfgangp distributionofprostatenodesapetctderivedanatomicatlasofprostatecancerpatientsbeforeandaftersurgicaltreatment AT stiefchristian distributionofprostatenodesapetctderivedanatomicatlasofprostatecancerpatientsbeforeandaftersurgicaltreatment AT belkaclaus distributionofprostatenodesapetctderivedanatomicatlasofprostatecancerpatientsbeforeandaftersurgicaltreatment AT ganswindtute distributionofprostatenodesapetctderivedanatomicatlasofprostatecancerpatientsbeforeandaftersurgicaltreatment |